date,symbol,close,rsi,26-Day EMA,NextDayClose,Diff,Titles,filename
2021-01-05,CVS,70.45999908447266,58.36735485079711,0.4087331192632926,72.55999755859375,1,Is PODD A Good Stock To Buy Now?,headlinesIter1.csv
2021-01-06,CVS,72.55999755859375,65.514693572197,0.4305743064502055,73.98999786376953,1,Is PODD A Good Stock To Buy Now?,headlinesIter2.csv
2021-01-07,CVS,73.98999786376953,69.37079081791147,0.5102569280459774,74.86000061035156,1,Is PODD A Good Stock To Buy Now?,headlinesIter3.csv
2021-01-08,CVS,74.86000061035156,71.46159231774631,0.6347337524081563,76.06999969482422,1,Is PODD A Good Stock To Buy Now?,headlinesIter4.csv
2021-01-11,CVS,76.06999969482422,74.1087462792366,0.7986195765181011,76.26000213623047,1,None,headlinesIter5.csv
2021-01-12,CVS,76.26000213623047,74.5086007547167,0.979826194905955,74.91999816894531,0,None,headlinesIter6.csv
2021-01-13,CVS,74.91999816894531,66.68658083396252,1.1387777984507363,75.05000305175781,1,None,headlinesIter7.csv
2021-01-14,CVS,75.05000305175781,67.04801759397941,1.2749265311530398,76.26000213623047,1,None,headlinesIter8.csv
2021-01-15,CVS,76.26000213623047,70.28002006383531,1.4060447378754457,75.4000015258789,0,None,headlinesIter9.csv
2021-01-19,CVS,75.4000015258789,65.37227350633744,1.5102110074823585,75.25,0,None,headlinesIter10.csv
2021-01-20,CVS,75.25,64.52589257197913,1.5861884939636757,74.08000183105469,0,None,headlinesIter11.csv
2021-01-21,CVS,74.08000183105469,58.19674573280243,1.6182330500172104,74.12000274658203,1,Bio-Rad's CEO Just Shared His Four-Part Plan For Success,headlinesIter12.csv
2021-01-22,CVS,74.12000274658203,58.347172482439234,1.6180113786104673,73.20999908447266,0,Bio-Rad's CEO Just Shared His Four-Part Plan For Success,headlinesIter13.csv
2021-01-25,CVS,73.20999908447266,53.620017679206896,1.579371129146522,74.2300033569336,1,"Bio-Rad to Report Fourth-Quarter and Full-Year 2020 Financial Results Thursday, February 11, 2021",headlinesIter14.csv
2021-01-26,CVS,74.2300033569336,57.75175078774699,1.5313503111356137,72.41999816894531,0,"Bio-Rad to Report Fourth-Quarter and Full-Year 2020 Financial Results Thursday, February 11, 2021",headlinesIter15.csv
2021-01-27,CVS,72.41999816894531,49.350304910280485,1.447599432353836,72.61000061035156,1,"Bio-Rad to Report Fourth-Quarter and Full-Year 2020 Financial Results Thursday, February 11, 2021",headlinesIter16.csv
2021-01-28,CVS,72.61000061035156,50.1697985128446,1.34557600920165,71.6500015258789,0,"Bio-Rad to Report Fourth-Quarter and Full-Year 2020 Financial Results Thursday, February 11, 2021",headlinesIter17.csv
2021-01-29,CVS,71.6500015258789,46.1103806315972,1.2190648810469038,71.45999908447266,0,"Bio-Rad to Report Fourth-Quarter and Full-Year 2020 Financial Results Thursday, February 11, 2021",headlinesIter18.csv
2021-02-01,CVS,71.45999908447266,45.32863212006119,1.0780273827519065,71.83000183105469,1,"Bio-Rad to Report Fourth-Quarter and Full-Year 2020 Financial Results Thursday, February 11, 2021",headlinesIter19.csv
2021-02-02,CVS,71.83000183105469,47.20572447235088,0.9387245910450313,73.23999786376953,1,"Bio-Rad to Report Fourth-Quarter and Full-Year 2020 Financial Results Thursday, February 11, 2021",headlinesIter20.csv
2021-02-03,CVS,73.23999786376953,53.72592657771247,0.8281676823215186,73.0,0,"Bio-Rad to Report Fourth-Quarter and Full-Year 2020 Financial Results Thursday, February 11, 2021",headlinesIter21.csv
2021-02-04,CVS,73.0,52.536575280302166,0.7357071245777388,72.18000030517578,0,10 Cheap Healthcare Stocks To Buy Now,headlinesIter22.csv
2021-02-05,CVS,72.18000030517578,48.57953401595197,0.6446765026953492,72.9800033569336,1,Bio-Rad (BIO) to Report Q4 Earnings: What's in the Cards?,headlinesIter23.csv
2021-02-08,CVS,72.9800033569336,52.35031646659611,0.5706083458267204,73.48999786376953,1,A Look Into Healthcare Sector Value Stocks,headlinesIter24.csv
2021-02-09,CVS,73.48999786376953,54.63424319742417,0.5178908412402281,73.83000183105469,1,A Look Into Healthcare Sector Value Stocks,headlinesIter25.csv
2021-02-10,CVS,73.83000183105469,56.14348704561637,0.4855632373097656,73.5999984741211,0,"Medical Products' Feb 11 Earnings Roster: DXCM, LH &amp; More",headlinesIter26.csv
2021-02-11,CVS,73.5999984741211,54.81497544397761,0.4629340284447494,74.20999908447266,1,Bio-Rad Reports Fourth-Quarter and Full-Year 2020 Financial Results,headlinesIter27.csv
2021-02-12,CVS,74.20999908447266,57.67545621241654,0.4562469294165623,70.52999877929688,0,Bio-Rad 4Q Sales Top Estimates Driven By COVID-19 Demand,headlinesIter28.csv
2021-02-16,CVS,70.52999877929688,40.86722737284998,0.4001504501425137,72.70999908447266,1,A Look Into Healthcare Sector Value Stocks,headlinesIter29.csv
2021-02-17,CVS,72.70999908447266,50.13760511204208,0.3498944065192448,71.5199966430664,0,A Look Into Healthcare Sector Value Stocks,headlinesIter30.csv
2021-02-18,CVS,71.5199966430664,45.90680740753331,0.286150265598966,70.41999816894531,0,A Look Into Healthcare Sector Value Stocks,headlinesIter31.csv
2021-02-19,CVS,70.41999816894531,42.34939059286266,0.1990915922571304,70.4800033569336,1,A Look Into Healthcare Sector Value Stocks,headlinesIter32.csv
2021-02-22,CVS,70.4800033569336,42.6106490615761,0.1024871589029749,69.63999938964844,0,"Bio-Rad to Participate in Citi’s 2021 Healthcare Services, Medtech, Tools, &amp; HCIT Virtual Conference",headlinesIter33.csv
2021-02-23,CVS,69.63999938964844,39.88568517245167,-0.0086715695307044,70.4000015258789,1,"Bio-Rad to Participate in Citi’s 2021 Healthcare Services, Medtech, Tools, &amp; HCIT Virtual Conference",headlinesIter34.csv
2021-02-24,CVS,70.4000015258789,43.41172502246208,-0.1109803694623931,69.33000183105469,0,Top Healthcare Stocks for March 2021,headlinesIter35.csv
2021-02-25,CVS,69.33000183105469,39.86629652115852,-0.2191972828022389,68.12999725341797,0,Top Healthcare Stocks for March 2021,headlinesIter36.csv
2021-02-26,CVS,68.12999725341797,36.28700745012085,-0.3440901549821611,69.27999877929688,1,Top Healthcare Stocks for March 2021,headlinesIter37.csv
2021-03-01,CVS,69.27999877929688,41.68999717215709,-0.4537562506031032,68.94000244140625,0,Top Healthcare Stocks for March 2021,headlinesIter38.csv
2021-03-02,CVS,68.94000244140625,40.59395317014431,-0.5525198604385851,69.02999877929688,1,Top Healthcare Stocks for March 2021,headlinesIter39.csv
2021-03-03,CVS,69.02999877929688,41.035848547880576,-0.6365775082389906,69.16999816894531,1,Top Healthcare Stocks for March 2021,headlinesIter40.csv
2021-03-04,CVS,69.16999816894531,41.76159391807981,-0.7033268057377805,70.62999725341797,1,Top Healthcare Stocks for March 2021,headlinesIter41.csv
2021-03-05,CVS,70.62999725341797,48.8343093709432,-0.7308319993677084,71.7300033569336,1,Bio-Rad to Participate in Barclays Global Healthcare Conference 2021,headlinesIter42.csv
2021-03-08,CVS,71.7300033569336,53.42383334297816,-0.7130822123904519,71.2300033569336,0,Bio-Rad to Participate in Barclays Global Healthcare Conference 2021,headlinesIter43.csv
2021-03-09,CVS,71.2300033569336,51.17674049944447,-0.6742499028402292,72.69999694824219,1,Bio-Rad to Participate in Barclays Global Healthcare Conference 2021,headlinesIter44.csv
2021-03-10,CVS,72.69999694824219,56.91455697302861,-0.5992494892902089,72.3499984741211,0,Bio-Rad to Participate in Barclays Global Healthcare Conference 2021,headlinesIter45.csv
2021-03-11,CVS,72.3499984741211,55.249669221685046,-0.5097294648940649,73.91999816894531,1,3 High-Quality Picks for the Value Investor,headlinesIter46.csv
2021-03-12,CVS,73.91999816894531,60.79045658858101,-0.3895914125771556,74.97000122070312,1,3 High-Quality Picks for the Value Investor,headlinesIter47.csv
2021-03-15,CVS,74.97000122070312,64.00074753165929,-0.2389202656737991,75.06999969482422,1,Here's Why You Should Add Bio-Rad (BIO) to Your Portfolio,headlinesIter48.csv
2021-03-16,CVS,75.06999969482422,64.30052701622357,-0.0748700322359307,74.01000213623047,0,Here's Why You Should Add Bio-Rad (BIO) to Your Portfolio,headlinesIter49.csv
2021-03-17,CVS,74.01000213623047,58.718645308723474,0.0722251711164668,74.4800033569336,1,Here's Why You Should Add Bio-Rad (BIO) to Your Portfolio,headlinesIter50.csv
2021-03-18,CVS,74.4800033569336,60.36172870182811,0.2083162956613326,73.18000030517578,0,Here's Why You Should Add Bio-Rad (BIO) to Your Portfolio,headlinesIter51.csv
2021-03-19,CVS,73.18000030517578,53.963814977133765,0.309160570759888,73.47000122070312,1,Here's Why You Should Add Bio-Rad (BIO) to Your Portfolio,headlinesIter52.csv
2021-03-22,CVS,73.47000122070312,55.10694479501906,0.3865485356884835,71.9000015258789,0,3 Health Care Stocks Trading Below Graham's Valuation,headlinesIter53.csv
2021-03-23,CVS,71.9000015258789,48.13797018356185,0.4192482843445875,73.20999908447266,1,3 Health Care Stocks Trading Below Graham's Valuation,headlinesIter54.csv
2021-03-24,CVS,73.20999908447266,53.43002304050631,0.4421688442412325,74.06999969482422,1,3 Health Care Stocks Trading Below Graham's Valuation,headlinesIter55.csv
2021-03-25,CVS,74.06999969482422,56.5636072538335,0.4704714796746163,75.95999908447266,1,Top Stocks for April 2021,headlinesIter56.csv
2021-03-26,CVS,75.95999908447266,62.53064935514887,0.5297453616162627,76.30000305175781,1,Analysts See Plenty of Potential for 10x Genomics,headlinesIter57.csv
2021-03-29,CVS,76.30000305175781,63.50201174033041,0.6095413539043352,76.08000183105469,0,Is Bio-Rad (BIO) Stock A Buy or Sell?,headlinesIter58.csv
2021-03-30,CVS,76.08000183105469,62.37522168156758,0.6931179105771732,75.2300033569336,0,Is Bio-Rad (BIO) Stock A Buy or Sell?,headlinesIter59.csv
2021-03-31,CVS,75.2300033569336,58.08667833668155,0.7595418454218855,74.30000305175781,0,Is Bio-Rad (BIO) Stock A Buy or Sell?,headlinesIter60.csv
2021-04-01,CVS,74.30000305175781,53.733629805015134,0.7951640355695841,75.04000091552734,1,Is Bio-Rad (BIO) Stock A Buy or Sell?,headlinesIter61.csv
2021-04-05,CVS,75.04000091552734,56.52542992195494,0.8196068088414761,74.62000274658203,0,"Logitech, Harley-Davidson, Fulgent Genetics, Bio-Rad Laboratories and IDEXX Laboratories highlighted as Zacks Bull and Bear of the Day",headlinesIter63.csv
2021-04-06,CVS,74.62000274658203,54.51478754831774,0.8271923344380229,74.48999786376953,0,"Logitech, Harley-Davidson, Fulgent Genetics, Bio-Rad Laboratories and IDEXX Laboratories highlighted as Zacks Bull and Bear of the Day",headlinesIter64.csv
2021-04-07,CVS,74.48999786376953,53.875961027809424,0.8198549273540767,73.79000091552734,0,"Logitech, Harley-Davidson, Fulgent Genetics, Bio-Rad Laboratories and IDEXX Laboratories highlighted as Zacks Bull and Bear of the Day",headlinesIter65.csv
2021-04-08,CVS,73.79000091552734,50.44801583990591,0.7905120964769603,74.06999969482422,1,"Logitech, Harley-Davidson, Fulgent Genetics, Bio-Rad Laboratories and IDEXX Laboratories highlighted as Zacks Bull and Bear of the Day",headlinesIter66.csv
2021-04-09,CVS,74.06999969482422,51.7699245227208,0.7515803719830962,74.45999908447266,1,"Logitech, Harley-Davidson, Fulgent Genetics, Bio-Rad Laboratories and IDEXX Laboratories highlighted as Zacks Bull and Bear of the Day",headlinesIter67.csv
2021-04-12,CVS,74.45999908447266,53.62563760861978,0.7131885888551783,74.0199966430664,0,A Trio of Stocks With a History of Sales and Earnings Growth,headlinesIter68.csv
2021-04-13,CVS,74.0199966430664,51.23067462271344,0.6685023081976394,75.08000183105469,1,Thermo Fisher (TMO) Rides on End Markets as Pandemic Rages On,headlinesIter69.csv
2021-04-14,CVS,75.08000183105469,56.29472254031596,0.6376013988043705,75.77999877929688,1,Thermo Fisher (TMO) Rides on End Markets as Pandemic Rages On,headlinesIter70.csv
2021-04-15,CVS,75.77999877929688,59.300217383603325,0.6266755897019489,75.87999725341797,1,"Bio-Rad to Report First-Quarter 2021 Financial Results, Thursday, April 29, 2021",headlinesIter71.csv
2021-04-16,CVS,75.87999725341797,59.726291971499045,0.6290096322655889,75.75,0,"Bio-Rad to Report First-Quarter 2021 Financial Results, Thursday, April 29, 2021",headlinesIter72.csv
2021-04-19,CVS,75.75,58.86358024077873,0.6360246681580319,75.91000366210938,1,"Bio-Rad to Report First-Quarter 2021 Financial Results, Thursday, April 29, 2021",headlinesIter73.csv
2021-04-20,CVS,75.91000366210938,59.636386478950286,0.6467090563160063,76.69999694824219,1,Is NICE Stock A Buy or Sell?,headlinesIter74.csv
2021-04-21,CVS,76.69999694824219,63.302138222226645,0.670263130837518,76.18000030517578,0,Is NICE Stock A Buy or Sell?,headlinesIter75.csv
2021-04-22,CVS,76.18000030517578,59.4733840405279,0.6908250239429059,76.05000305175781,0,Bio-Rad Laboratories (BIO) Earnings Expected to Grow: What to Know Ahead of Next Week's Release,headlinesIter76.csv
2021-04-23,CVS,76.05000305175781,58.520445163053445,0.704785027068288,75.75,0,Bio-Rad Laboratories (BIO) Earnings Expected to Grow: What to Know Ahead of Next Week's Release,headlinesIter77.csv
2021-04-26,CVS,75.75,56.27931353005161,0.7074825659070412,75.11000061035156,0,BioRad (BIO) to Report Q1 Earnings: What's in the Cards?,headlinesIter78.csv
2021-04-27,CVS,75.11000061035156,51.728122827368615,0.6911562885279936,75.4000015258789,1,BioRad (BIO) to Report Q1 Earnings: What's in the Cards?,headlinesIter79.csv
2021-04-28,CVS,75.4000015258789,53.56071675322214,0.6668136123796826,76.37000274658203,1,BioRad (BIO) to Report Q1 Earnings: What's in the Cards?,headlinesIter80.csv
2021-04-29,CVS,76.37000274658203,59.147346852981954,0.652678495940559,76.4000015258789,1,Bio-Rad Laboratories (BIO) Q1 Earnings and Revenues Beat Estimates,headlinesIter81.csv
2021-04-30,CVS,76.4000015258789,59.31037555680918,0.6446732930222647,77.69000244140625,1,"Is It Too Late To Consider Buying Bio-Rad Laboratories, Inc. (NYSE:BIO)?",headlinesIter82.csv
2021-05-03,CVS,77.69000244140625,65.65712775680352,0.6600417174567209,81.12000274658203,1,Top Stocks for May 2021,headlinesIter83.csv
2021-05-04,CVS,81.12000274658203,76.26023408649569,0.7424739234952509,83.04000091552734,1,Top Stocks for May 2021,headlinesIter84.csv
2021-05-05,CVS,83.04000091552734,79.98532143819699,0.8915593773089515,83.69999694824219,1,Top Stocks for May 2021,headlinesIter85.csv
2021-05-06,CVS,83.69999694824219,81.08410491345394,1.083104296768582,85.11000061035156,1,Top Stocks for May 2021,headlinesIter86.csv
2021-05-07,CVS,85.11000061035156,83.20538125396435,1.311248056668228,85.8499984741211,1,Top Stocks for May 2021,headlinesIter87.csv
2021-05-10,CVS,85.8499984741211,84.20640906961923,1.559189221999283,84.37000274658203,0,"Was The Smart Money Right About Bio-Rad Laboratories, Inc. (BIO)?",headlinesIter88.csv
2021-05-11,CVS,84.37000274658203,74.62606284016643,1.7793753568488566,83.37999725341797,0,"Was The Smart Money Right About Bio-Rad Laboratories, Inc. (BIO)?",headlinesIter89.csv
2021-05-12,CVS,83.37999725341797,68.97308197513595,1.9507721394638,84.2699966430664,1,"Was The Smart Money Right About Bio-Rad Laboratories, Inc. (BIO)?",headlinesIter90.csv
2021-05-13,CVS,84.2699966430664,71.09303514863237,2.092357014895628,84.33000183105469,1,"Was The Smart Money Right About Bio-Rad Laboratories, Inc. (BIO)?",headlinesIter91.csv
2021-05-14,CVS,84.33000183105469,71.23573538107641,2.204022694180979,84.55999755859375,1,"Was The Smart Money Right About Bio-Rad Laboratories, Inc. (BIO)?",headlinesIter92.csv
2021-05-17,CVS,84.55999755859375,71.81015663427677,2.289727935482851,88.61000061035156,1,"Was The Smart Money Right About Bio-Rad Laboratories, Inc. (BIO)?",headlinesIter93.csv
2021-05-18,CVS,88.61000061035156,79.5533441572316,2.4140655469987875,89.20999908447266,1,"Was The Smart Money Right About Bio-Rad Laboratories, Inc. (BIO)?",headlinesIter94.csv
2021-05-19,CVS,89.20999908447266,80.41176811460714,2.5601696782089696,89.06999969482422,0,"Was The Smart Money Right About Bio-Rad Laboratories, Inc. (BIO)?",headlinesIter95.csv
2021-05-20,CVS,89.06999969482422,79.57230396196218,2.704188869230744,89.80999755859375,1,Bio-Rad to Participate at Jefferies Virtual Healthcare Conference,headlinesIter96.csv
2021-05-21,CVS,89.80999755859375,80.71813501626995,2.844994376450449,89.70999908447266,0,Bio-Rad to Participate at Jefferies Virtual Healthcare Conference,headlinesIter97.csv
2021-05-24,CVS,89.70999908447266,80.0645694477587,2.9683246166458344,88.69999694824219,0,Bio-Rad to Participate at Jefferies Virtual Healthcare Conference,headlinesIter98.csv
2021-05-25,CVS,88.69999694824219,73.5839743382225,3.0513571166100157,87.31999969482422,0,Bio-Rad to Participate at Jefferies Virtual Healthcare Conference,headlinesIter99.csv
2021-05-26,CVS,87.31999969482422,65.75275990612006,3.0758073625495954,86.41999816894531,0,Bio-Rad to Participate at Jefferies Virtual Healthcare Conference,headlinesIter100.csv
2021-05-27,CVS,86.41999816894531,61.17973885049659,3.040888278444557,86.44000244140625,1,Bio-Rad to Participate at Jefferies Virtual Healthcare Conference,headlinesIter101.csv
2021-05-28,CVS,86.44000244140625,61.244258123893005,2.96397652152112,85.87000274658203,0,Bio-Rad to Participate at Jefferies Virtual Healthcare Conference,headlinesIter102.csv
2021-06-01,CVS,85.87000274658203,58.27238441628856,2.8489268979284827,85.98999786376953,1,Bio-Rad to Participate at Jefferies Virtual Healthcare Conference,headlinesIter103.csv
2021-06-02,CVS,85.98999786376953,58.72644156693564,2.711425461073134,87.05999755859375,1,Bio-Rad to Participate at Jefferies Virtual Healthcare Conference,headlinesIter104.csv
2021-06-03,CVS,87.05999755859375,62.63125449251439,2.577951048270487,86.47000122070312,0,Bio-Rad to Participate at Jefferies Virtual Healthcare Conference,headlinesIter105.csv
2021-06-04,CVS,86.47000122070312,59.29981447025153,2.438708926511596,86.33000183105469,0,Bio-Rad to Participate at Jefferies Virtual Healthcare Conference,headlinesIter106.csv
2021-06-07,CVS,86.33000183105469,58.50458529840823,2.295359099187892,85.80999755859375,0,Bio-Rad to Participate at Jefferies Virtual Healthcare Conference,headlinesIter107.csv
2021-06-08,CVS,85.80999755859375,55.526060088595,2.1434213242669395,84.94999694824219,0,Bio-Rad to Participate at Jefferies Virtual Healthcare Conference,headlinesIter108.csv
2021-06-09,CVS,84.94999694824219,50.909809481952685,1.9754595211686885,85.5,1,Bio-Rad to Participate at Jefferies Virtual Healthcare Conference,headlinesIter109.csv
2021-06-10,CVS,85.5,53.5684332356629,1.8105315085288745,85.47000122070312,0,S&amp;P 500 Rides Falling Yields to Record Highs as Bond Bears Cower,headlinesIter110.csv
2021-06-11,CVS,85.47000122070312,53.39856393156232,1.6515456353834843,84.62000274658203,0,S&amp;P 500 Rides Falling Yields to Record Highs as Bond Bears Cower,headlinesIter111.csv
2021-06-14,CVS,84.62000274658203,48.68746353326017,1.4872930465436889,85.4000015258789,1,S&amp;P 500 Rides Falling Yields to Record Highs as Bond Bears Cower,headlinesIter112.csv
2021-06-15,CVS,85.4000015258789,52.80248735654423,1.337404357728708,84.73999786376953,0,S&amp;P 500 Rides Falling Yields to Record Highs as Bond Bears Cower,headlinesIter113.csv
2021-06-16,CVS,84.73999786376953,49.20657488043123,1.190797907904209,84.2300033569336,0,S&amp;P 500 Rides Falling Yields to Record Highs as Bond Bears Cower,headlinesIter114.csv
2021-06-17,CVS,84.2300033569336,46.56755878395756,1.0430833204445893,82.4000015258789,0,Hedge Funds Keep Betting On L Brands Inc (LB),headlinesIter115.csv
2021-06-21,CVS,84.0199966430664,47.21248378068649,0.7161223605441143,83.80999755859375,0,Bio-Rad Launches Its PREvalence ddPCR SARS-CoV-2 Wastewater Quantification Kit for COVID-19 Wastewater Testing,headlinesIter116.csv
2021-06-22,CVS,83.80999755859375,46.30337598599312,0.5755094899923152,83.7300033569336,0,Bio-Rad Launches Its PREvalence ddPCR SARS-CoV-2 Wastewater Quantification Kit for COVID-19 Wastewater Testing,headlinesIter117.csv
2021-06-23,CVS,83.7300033569336,45.94048191729132,0.4485226726357877,83.7699966430664,1,Top Healthcare Stocks for July 2021,headlinesIter118.csv
2021-06-24,CVS,83.7699966430664,46.16763776225866,0.3363490558677385,84.08000183105469,1,10 Medical Device Stocks for 2021,headlinesIter119.csv
2021-06-25,CVS,84.08000183105469,47.99190820169776,0.2435197367807058,84.12000274658203,1,10 Medical Device Stocks for 2021,headlinesIter120.csv
2021-06-28,CVS,84.12000274658203,48.23566798224268,0.1677644755243087,83.48999786376953,0,Hedge Funds Aren’t Crazy About Quest Diagnostics Incorporated (DGX) Anymore,headlinesIter121.csv
2021-06-29,CVS,83.48999786376953,44.6834735862945,0.0962483897826934,83.44000244140625,0,Hedge Funds Aren’t Crazy About Quest Diagnostics Incorporated (DGX) Anymore,headlinesIter122.csv
2021-06-30,CVS,83.44000244140625,44.40401230138029,0.0301213112030062,82.22000122070312,0,Bio-Rad Announces Partnership with Seegene for Molecular Diagnostic Testing Products,headlinesIter123.csv
2021-07-01,CVS,82.22000122070312,38.136065317255856,-0.0486946108621776,82.43000030517578,1,Bio-Rad Announces Partnership with Seegene for Molecular Diagnostic Testing Products,headlinesIter124.csv
2021-07-02,CVS,82.43000030517578,39.71354815808609,-0.1278705957167429,81.18000030517578,0,Bio-Rad Announces Partnership with Seegene for Molecular Diagnostic Testing Products,headlinesIter125.csv
2021-07-06,CVS,81.18000030517578,34.13408222104387,-0.2227733019837499,81.33999633789062,1,Bio-Rad Announces Partnership with Seegene for Molecular Diagnostic Testing Products,headlinesIter126.csv
2021-07-07,CVS,81.33999633789062,35.38540245782024,-0.31949786719843,80.22000122070312,0,Bio-Rad Announces Partnership with Seegene for Molecular Diagnostic Testing Products,headlinesIter127.csv
2021-07-08,CVS,80.22000122070312,30.95243860466369,-0.429434544467325,81.31999969482422,1,Bio-Rad Announces Partnership with Seegene for Molecular Diagnostic Testing Products,headlinesIter128.csv
2021-07-09,CVS,81.31999969482422,39.03109410691582,-0.5233606539286043,81.81999969482422,1,Bio-Rad Announces Partnership with Seegene for Molecular Diagnostic Testing Products,headlinesIter129.csv
2021-07-12,CVS,81.81999969482422,42.33383439287916,-0.593157835028332,81.66000366210938,0,"Here is What Hedge Funds Think About Tyler Technologies, Inc. (TYL)",headlinesIter130.csv
2021-07-13,CVS,81.66000366210938,41.55804291845795,-0.6453733042859053,82.41999816894531,1,"Here is What Hedge Funds Think About Tyler Technologies, Inc. (TYL)",headlinesIter131.csv
2021-07-14,CVS,82.41999816894531,46.5670586999926,-0.6702354712035268,82.06999969482422,0,"Bio-Rad to Report Second-Quarter 2021 Financial Results, Thursday, July 29, 2021",headlinesIter132.csv
2021-07-15,CVS,82.06999969482422,44.66830973972,-0.6807062212893591,81.72000122070312,0,"Bio-Rad to Report Second-Quarter 2021 Financial Results, Thursday, July 29, 2021",headlinesIter133.csv
2021-07-16,CVS,81.72000122070312,42.78938464950623,-0.6856403701600158,80.66999816894531,0,"Bio-Rad to Report Second-Quarter 2021 Financial Results, Thursday, July 29, 2021",headlinesIter134.csv
2021-07-19,CVS,80.66999816894531,37.67003218178606,-0.7020351007604632,81.80000305175781,1,"Bio-Rad to Report Second-Quarter 2021 Financial Results, Thursday, July 29, 2021",headlinesIter135.csv
2021-07-20,CVS,81.80000305175781,45.26028075086705,-0.7051250151590506,83.05999755859375,1,"Bio-Rad to Report Second-Quarter 2021 Financial Results, Thursday, July 29, 2021",headlinesIter136.csv
2021-07-21,CVS,83.05999755859375,52.24362518659413,-0.6780041510968082,82.62999725341797,0,"Bio-Rad to Report Second-Quarter 2021 Financial Results, Thursday, July 29, 2021",headlinesIter137.csv
2021-07-22,CVS,82.62999725341797,49.90382110937176,-0.6386845720074126,83.2699966430664,1,Bio-Rad Laboratories (BIO) Earnings Expected to Grow: Should You Buy?,headlinesIter138.csv
2021-07-23,CVS,83.2699966430664,53.25917290430986,-0.5821137641705342,82.87000274658203,0,Bio-Rad Laboratories (BIO) Earnings Expected to Grow: Should You Buy?,headlinesIter139.csv
2021-07-26,CVS,82.87000274658203,50.96177361649949,-0.5227506695778982,83.63999938964844,1,"The Week Ahead In Biotech (July 25-31): Big Pharma Earnings, Iterum FDA Decision, Alzheimer's Conference, IPOs and More",headlinesIter140.csv
2021-07-27,CVS,83.63999938964844,54.98708391131271,-0.451273034009204,83.30000305175781,0,10x Genomics Signs Global Patent Cross License Agreement with Bio-Rad,headlinesIter141.csv
2021-07-28,CVS,83.30000305175781,52.92139012005889,-0.3803451150921085,83.05999755859375,0,10x Genomics Signs Global Patent Cross License Agreement with Bio-Rad,headlinesIter142.csv
2021-07-29,CVS,83.05999755859375,51.451993332311964,-0.3164421706510013,82.36000061035156,0,Bio-Rad Laboratories (BIO) Q2 Earnings and Revenues Beat Estimates,headlinesIter143.csv
2021-07-30,CVS,82.36000061035156,47.3247871966447,-0.2707390488197775,82.41000366210938,1,Bio-Rad Laboratories (BIO) Q2 Earnings and Revenues Beat Estimates,headlinesIter144.csv
2021-08-02,CVS,82.41000366210938,47.64784006964336,-0.237424217834618,84.0,1,Bio-Rad Laboratories (BIO) Q2 Earnings and Revenues Beat Estimates,headlinesIter145.csv
2021-08-03,CVS,84.0,56.73431079633495,-0.1877119452819551,81.55000305175781,0,Bio-Rad Laboratories (BIO) Q2 Earnings and Revenues Beat Estimates,headlinesIter146.csv
2021-08-04,CVS,81.55000305175781,44.04787350752962,-0.1689885104046461,80.05000305175781,0,Bio-Rad Laboratories (BIO) Q2 Earnings and Revenues Beat Estimates,headlinesIter147.csv
2021-08-05,CVS,80.05000305175781,38.38807889666796,-0.1942162569575265,81.25,1,Bio-Rad Laboratories (BIO) Q2 Earnings and Revenues Beat Estimates,headlinesIter148.csv
2021-08-06,CVS,81.25,44.52876789538354,-0.2260813638019941,81.6500015258789,1,Bio-Rad Laboratories (BIO) Q2 Earnings and Revenues Beat Estimates,headlinesIter149.csv
2021-08-09,CVS,81.6500015258789,46.44487413958602,-0.2535391420488754,83.23999786376953,1,"What Makes Bio-Rad (BIO) a Good Fit for ""Trend Investing""",headlinesIter150.csv
2021-08-10,CVS,83.23999786376953,53.34378366119537,-0.2508497800762738,84.94999694824219,1,Here's Why You Should Add Bio-Rad (BIO) to Your Portfolio,headlinesIter151.csv
2021-08-11,CVS,84.94999694824219,59.40107395507205,-0.2015519813939913,85.13999938964844,1,Surging Earnings Estimates Signal Upside for Bio-Rad (BIO) Stock,headlinesIter152.csv
2021-08-12,CVS,85.13999938964844,60.02213804988448,-0.1221344338873031,84.36000061035156,0,Surging Earnings Estimates Signal Upside for Bio-Rad (BIO) Stock,headlinesIter153.csv
2021-08-13,CVS,84.36000061035156,56.21996505208584,-0.0401676662943083,85.38999938964844,1,Surging Earnings Estimates Signal Upside for Bio-Rad (BIO) Stock,headlinesIter154.csv
2021-08-16,CVS,85.38999938964844,59.83792706570411,0.055624648855309,86.47000122070312,1,Surging Earnings Estimates Signal Upside for Bio-Rad (BIO) Stock,headlinesIter155.csv
2021-08-17,CVS,86.47000122070312,63.26584501409452,0.1721649765363381,84.58999633789062,0,"The Daily Biotech Pulse: Lilly Reorganizes Business Units In Neuroscience Focus, Helius Medical Spikes On Breakthrough Designation, Ra Medical Sells Dermatology Business",headlinesIter156.csv
2021-08-18,CVS,84.58999633789062,54.53928800252123,0.2652137412618129,84.2300033569336,0,"The Daily Biotech Pulse: Lilly Reorganizes Business Units In Neuroscience Focus, Helius Medical Spikes On Breakthrough Designation, Ra Medical Sells Dermatology Business",headlinesIter157.csv
2021-08-19,CVS,84.2300033569336,53.03086864391622,0.3323127259088287,84.8499984741211,1,5 Stocks With Recent Price Strength Amid Robust Reopening,headlinesIter158.csv
2021-08-20,CVS,84.8499984741211,55.32267899372327,0.3887637035494526,84.5999984741211,0,5 Stocks With Recent Price Strength Amid Robust Reopening,headlinesIter159.csv
2021-08-23,CVS,84.5999984741211,54.17479021865472,0.430706788048103,83.80999755859375,0,5 Stocks With Recent Price Strength Amid Robust Reopening,headlinesIter160.csv
2021-08-24,CVS,83.80999755859375,50.60177683712482,0.4477722092891987,83.56999969482422,0,5 Stocks With Recent Price Strength Amid Robust Reopening,headlinesIter161.csv
2021-08-25,CVS,83.56999969482422,49.53297719082956,0.4435006063934315,83.02999877929688,0,5 Stocks With Recent Price Strength Amid Robust Reopening,headlinesIter162.csv
2021-08-26,CVS,83.02999877929688,47.12129775287852,0.4164530678028056,83.70999908447266,1,5 Stocks With Recent Price Strength Amid Robust Reopening,headlinesIter163.csv
2021-08-27,CVS,83.70999908447266,50.39649038744659,0.3864477175652864,84.5999984741211,1,5 Stocks With Recent Price Strength Amid Robust Reopening,headlinesIter164.csv
2021-08-30,CVS,84.5999984741211,54.37924722821628,0.3694800262737293,86.38999938964844,1,"Catalent's (CTLT) Q4 Earnings Top Estimates, Margins Rise",headlinesIter165.csv
2021-08-31,CVS,86.38999938964844,61.13771102003225,0.3892898608904646,85.70999908447266,0,Bio-Rad to Participate in the 2021 Virtual Wells Fargo Healthcare Conference,headlinesIter166.csv
2021-09-01,CVS,85.70999908447266,57.64405148635841,0.4193763939265154,86.95999908447266,1,Bio-Rad to Participate in the 2021 Virtual Wells Fargo Healthcare Conference,headlinesIter167.csv
2021-09-02,CVS,86.95999908447266,61.94860023866402,0.473314152971812,87.47000122070312,1,Patterson Companies (PDCO) Q1 Earnings &amp; Revenues Top Estimates,headlinesIter168.csv
2021-09-03,CVS,87.47000122070312,63.57511523305925,0.5464318994704247,86.58000183105469,0,Cooper Companies (COO) Q3 Earnings &amp; Revenues Beat Estimates,headlinesIter169.csv
2021-09-07,CVS,86.58000183105469,58.84774459408143,0.6122934881415384,86.22000122070312,0,Cooper Companies (COO) Q3 Earnings &amp; Revenues Beat Estimates,headlinesIter170.csv
2021-09-08,CVS,86.22000122070312,57.00138570070591,0.6630153441571532,85.41000366210938,0,Cooper Companies (COO) Q3 Earnings &amp; Revenues Beat Estimates,headlinesIter171.csv
2021-09-09,CVS,85.41000366210938,52.97407756690789,0.6871548014880156,83.79000091552734,0,HealthEquity (HQY) Q2 Earnings &amp; Revenues Beat Estimates,headlinesIter172.csv
2021-09-10,CVS,83.79000091552734,45.97741792395463,0.6659551336120859,84.51000213623047,1,HealthEquity (HQY) Q2 Earnings &amp; Revenues Beat Estimates,headlinesIter173.csv
2021-09-13,CVS,84.51000213623047,49.18947457237765,0.6274184545466133,83.88999938964844,0,Here's Why You Should Add Bio-Rad (BIO) to Your Portfolio Now,headlinesIter174.csv
2021-09-14,CVS,83.88999938964844,46.6189856208522,0.5687136338532461,85.54000091552734,1,Bio-Rad Laboratories (BIO) Is Up 0.05% in One Week: What You Should Know,headlinesIter175.csv
2021-09-15,CVS,85.54000091552734,53.57235956817523,0.5254738136740116,85.3499984741211,0,Bio-Rad Laboratories (BIO) Is Up 0.05% in One Week: What You Should Know,headlinesIter176.csv
2021-09-16,CVS,85.3499984741211,52.72073199483379,0.4899648199380635,85.51000213623047,1,Bio-Rad (BIO) Upgraded to Strong Buy: Here's Why,headlinesIter177.csv
2021-09-17,CVS,85.51000213623047,53.392653806106296,0.4625988346184306,84.58000183105469,0,Bio-Rad (BIO) Upgraded to Strong Buy: Here's Why,headlinesIter178.csv
2021-09-20,CVS,84.58000183105469,49.03095014394946,0.4258793313637294,83.93000030517578,0,10 Healthcare Stocks to Buy According to Mario Gabelli,headlinesIter179.csv
2021-09-21,CVS,83.93000030517578,46.19077041843666,0.3738810614542088,83.86000061035156,0,10 Healthcare Stocks to Buy According to Mario Gabelli,headlinesIter180.csv
2021-09-22,CVS,83.86000061035156,45.8825301838932,0.3130632370207473,84.86000061035156,1,10 Healthcare Stocks to Buy According to Mario Gabelli,headlinesIter181.csv
2021-09-23,CVS,84.86000061035156,50.92120728911691,0.2651465390393992,84.70999908447266,0,10 Healthcare Stocks to Buy According to Mario Gabelli,headlinesIter182.csv
2021-09-24,CVS,84.70999908447266,50.16668031840774,0.2248303803348845,85.73999786376953,1,10 Healthcare Stocks to Buy According to Mario Gabelli,headlinesIter183.csv
2021-09-27,CVS,85.73999786376953,55.0878224169259,0.2073121271029053,85.66000366210938,0,10 Healthcare Stocks to Buy According to Mario Gabelli,headlinesIter184.csv
2021-09-28,CVS,85.66000366210938,54.63655304262795,0.2032527280944232,86.79000091552734,1,10 Healthcare Stocks to Buy According to Mario Gabelli,headlinesIter185.csv
2021-09-29,CVS,86.79000091552734,59.66327076690965,0.2254070707030083,84.86000061035156,0,10 Healthcare Stocks to Buy According to Mario Gabelli,headlinesIter186.csv
2021-09-30,CVS,84.86000061035156,49.56169211700336,0.2315245354945274,84.06999969482422,0,"Bio Rad (BIO) Global Growth Strong, Expenses Continue to Rise",headlinesIter187.csv
2021-10-01,CVS,84.06999969482422,46.11959900280836,0.2141380138835772,83.80999755859375,0,"Bio Rad (BIO) Global Growth Strong, Expenses Continue to Rise",headlinesIter188.csv
2021-10-04,CVS,83.80999755859375,45.011611017209326,0.178294833056387,83.63999938964844,0,Do Hedge Funds Love Coupa Software Incorporated (COUP)?,headlinesIter189.csv
2021-10-05,CVS,83.63999938964844,44.26285392043736,0.1296437430756635,83.1500015258789,0,Do Hedge Funds Love Coupa Software Incorporated (COUP)?,headlinesIter190.csv
2021-10-06,CVS,83.1500015258789,42.08952696831801,0.067402160246785,84.19999694824219,1,Do Hedge Funds Love Coupa Software Incorporated (COUP)?,headlinesIter191.csv
2021-10-07,CVS,84.19999694824219,47.98345780174937,0.0165035669748696,84.37000274658203,1,Do Hedge Funds Love Coupa Software Incorporated (COUP)?,headlinesIter192.csv
2021-10-08,CVS,84.37000274658203,48.890465267239264,-0.0219425435738026,84.27999877929688,0,Do Hedge Funds Love Coupa Software Incorporated (COUP)?,headlinesIter193.csv
2021-10-12,CVS,83.79000091552734,45.76781143534577,-0.0828053098645532,83.16000366210938,0,"Hedge Funds Aren’t Crazy About Bio-Rad Laboratories, Inc. (BIO) Anymore",headlinesIter194.csv
2021-10-13,CVS,83.16000366210938,42.552937996046346,-0.1224277713464425,84.55999755859375,1,"Hedge Funds Aren’t Crazy About Bio-Rad Laboratories, Inc. (BIO) Anymore",headlinesIter195.csv
2021-10-14,CVS,84.55999755859375,50.82021567115338,-0.1428557609781859,85.83999633789062,1,"Hedge Funds Aren’t Crazy About Bio-Rad Laboratories, Inc. (BIO) Anymore",headlinesIter196.csv
2021-10-15,CVS,85.83999633789062,56.923987529749965,-0.1294349284187602,84.4800033569336,0,"Bio-Rad to Report Third-Quarter 2021 Financial Results, Thursday, October 28, 2021",headlinesIter197.csv
2021-10-18,CVS,84.4800033569336,49.84537222102623,-0.1169047374196195,84.88999938964844,1,Hedge Funds Are Piling Into Cenovus Energy Inc (CVE),headlinesIter198.csv
2021-10-19,CVS,84.88999938964844,51.79164185894118,-0.0987819398236347,86.55000305175781,1,11 Best Genomic Stocks to Buy Now,headlinesIter199.csv
2021-10-20,CVS,86.55000305175781,58.76816081365798,-0.0513942988224926,86.86000061035156,1,Here's Why You Should Retain Bio-Rad (BIO) Stock For Now,headlinesIter200.csv
2021-10-21,CVS,86.86000061035156,59.93422875548706,0.0169148086227988,87.5199966430664,1,Analysts Estimate Bio-Rad Laboratories (BIO) to Report a Decline in Earnings: What to Look Out for,headlinesIter201.csv
2021-10-22,CVS,87.5199966430664,62.373988530248894,0.1052475085952253,87.68000030517578,1,9 Moonshot Bets to Beat Hedge Funds at Their Own Game,headlinesIter202.csv
2021-10-25,CVS,87.68000030517578,62.962811645847886,0.2038129469648413,88.31999969482422,1,Hedge Funds Are Dumping Just Eat Takeaway.com N.V. (GRUB),headlinesIter203.csv
2021-10-26,CVS,88.31999969482422,65.3018498221006,0.3133713899095025,88.08999633789062,0,Hedge Funds Are Dumping Just Eat Takeaway.com N.V. (GRUB),headlinesIter204.csv
2021-10-27,CVS,88.08999633789062,63.74381678516141,0.4196929945224614,88.62000274658203,1,"Is Now The Time To Look At Buying Bio-Rad Laboratories, Inc. (NYSE:BIO)?",headlinesIter205.csv
2021-10-28,CVS,88.62000274658203,65.77048895436293,0.5259116348482431,89.27999877929688,1,Bio-Rad Laboratories (BIO) Surpasses Q3 Earnings and Revenue Estimates,headlinesIter206.csv
2021-10-29,CVS,89.27999877929688,68.15749507630923,0.6358287747471032,90.6500015258789,1,"Bio-Rad (BIO) Q3 Earnings Surpass Estimates, 2021 View Raised",headlinesIter207.csv
2021-11-01,CVS,90.6500015258789,72.45195382906346,0.7627104357086404,91.1500015258789,1,"Bio-Rad (BIO) Q3 Earnings Surpass Estimates, 2021 View Raised",headlinesIter208.csv
2021-11-02,CVS,91.1500015258789,73.83869031674894,0.899812620099038,96.33999633789062,1,"Bio-Rad (BIO) Q3 Earnings Surpass Estimates, 2021 View Raised",headlinesIter209.csv
2021-11-03,CVS,96.33999633789062,83.25901332182393,1.1168861885713512,94.48999786376952,0,"Bio-Rad (BIO) Q3 Earnings Surpass Estimates, 2021 View Raised",headlinesIter210.csv
2021-11-04,CVS,94.48999786376952,73.14793422175134,1.3406436614088943,93.77999877929688,0,"Recent Price Trend in Bio-Rad (BIO) is Your Friend, Here's Why",headlinesIter211.csv
2021-11-05,CVS,93.77999877929688,69.65194106533106,1.54247752073637,93.76000213623048,0,"Recent Price Trend in Bio-Rad (BIO) is Your Friend, Here's Why",headlinesIter212.csv
2021-11-08,CVS,93.76000213623048,69.55111876135155,1.7161549663840678,92.76000213623048,0,Were Hedge Funds Right About Coupa Software Incorporated (COUP)?,headlinesIter213.csv
2021-11-09,CVS,92.76000213623048,64.52128114249716,1.843214178463174,92.95999908447266,1,Were Hedge Funds Right About Coupa Software Incorporated (COUP)?,headlinesIter214.csv
2021-11-10,CVS,92.95999908447266,65.06542454325583,1.9333831075794303,94.20999908447266,1,Were Hedge Funds Right About Coupa Software Incorporated (COUP)?,headlinesIter215.csv
2021-11-12,CVS,94.0199966430664,67.30344092598656,2.0696820436563024,93.48999786376952,0,Here's Why You Should Add Chemed (CHE) to Your Portfolio Now,headlinesIter216.csv
2021-11-15,CVS,93.48999786376952,64.38554060733027,2.0997195168868688,92.88999938964844,0,10 Healthcare Stocks to Buy According to John Rogers’ Ariel Investments,headlinesIter217.csv
2021-11-16,CVS,92.88999938964844,61.15323384387929,2.0960203592441538,92.7300033569336,0,10 Healthcare Stocks to Buy According to John Rogers’ Ariel Investments,headlinesIter218.csv
2021-11-17,CVS,92.7300033569336,60.284131375410944,2.064039753276381,95.33999633789062,1,10 Healthcare Stocks to Buy According to John Rogers’ Ariel Investments,headlinesIter219.csv
2021-11-18,CVS,95.33999633789062,68.21891493868829,2.052945909157707,93.16000366210938,0,10 Healthcare Stocks to Buy According to John Rogers’ Ariel Investments,headlinesIter220.csv
2021-11-19,CVS,93.16000366210938,57.82686862482405,2.016065451440409,92.98999786376952,0,10 Healthcare Stocks to Buy According to John Rogers’ Ariel Investments,headlinesIter221.csv
2021-11-22,CVS,92.98999786376952,57.0964053001372,1.9576484142315032,93.63999938964844,1,Is Bio-Rad Laboratories (BIO) Outperforming Other Medical Stocks This Year?,headlinesIter222.csv
2021-11-23,CVS,93.63999938964844,59.217582879033536,1.8947035018374887,92.6500015258789,0,Is Bio-Rad Laboratories (BIO) Outperforming Other Medical Stocks This Year?,headlinesIter223.csv
2021-11-24,CVS,92.6500015258789,54.77561727112303,1.8121070310638363,91.5199966430664,0,Is Bio-Rad Laboratories (BIO) Outperforming Other Medical Stocks This Year?,headlinesIter224.csv
2021-11-26,CVS,91.5199966430664,50.15139911517078,1.699364461287656,92.0199966430664,1,Bio Rad (BIO) Grows Internationally on New Product Launches,headlinesIter225.csv
2021-11-29,CVS,92.0199966430664,52.07914574747876,1.5777410651134611,89.05999755859375,0,Bio Rad (BIO) Grows Internationally on New Product Launches,headlinesIter226.csv
2021-11-30,CVS,89.05999755859375,41.778659307606326,1.406105990753807,88.77999877929688,0,Top Stocks for December 2021,headlinesIter227.csv
2021-12-01,CVS,88.77999877929688,40.95350680107811,1.2044499426356103,89.98999786376953,1,Top Stocks for December 2021,headlinesIter228.csv
2021-12-02,CVS,89.98999786376953,45.92398308956299,1.0111081166753433,90.87000274658205,1,Top Stocks for December 2021,headlinesIter229.csv
2021-12-03,CVS,90.87000274658205,49.26873790024059,0.8448482261077359,92.6500015258789,1,Top Stocks for December 2021,headlinesIter230.csv
2021-12-06,CVS,92.6500015258789,55.292395752858326,0.7307516470956983,92.93000030517578,1,Top Stocks for December 2021,headlinesIter231.csv
2021-12-07,CVS,92.93000030517578,56.17392817867187,0.6581328385749237,93.0999984741211,1,10 Biotech Stocks to Buy According to Billionaire Ken Fisher,headlinesIter232.csv
2021-12-08,CVS,93.0999984741211,56.73175445595717,0.6165304946128218,97.30999755859376,1,"AmericaFirst Defensive Growth Fund Buys HCA Healthcare Inc, Bio-Rad Laboratories Inc, Pfizer ...",headlinesIter233.csv
2021-12-09,CVS,97.30999755859376,67.69725183085146,0.662312412215298,98.86000061035156,1,Hedge Funds Are Coming Back To Hormel Foods Corporation (HRL),headlinesIter234.csv
2021-12-10,CVS,98.86000061035156,70.64676448655048,0.7836849777391206,98.9000015258789,1,Hedge Funds Are Buying Dover Corporation (DOV),headlinesIter235.csv
2021-12-13,CVS,98.9000015258789,70.72106437106038,0.944925761159868,98.77999877929688,0,"Penn Series Large Cap Value Fund Buys Raytheon Technologies Corp, Cognizant Technology ...",headlinesIter236.csv
2021-12-14,CVS,98.77999877929688,70.14741074536582,1.1186344121948444,100.5500030517578,1,"Penn Series Large Cap Value Fund Buys Raytheon Technologies Corp, Cognizant Technology ...",headlinesIter237.csv
2021-12-15,CVS,100.5500030517578,73.55475741426515,1.3167413768825589,101.22000122070312,1,"Franklin DynaTech VIP Fund Buys Intuitive Surgical Inc, Moderna Inc, Airbnb Inc, Sells Nintendo ...",headlinesIter238.csv
2021-12-16,CVS,101.22000122070312,74.73050698628496,1.5274439469775,100.36000061035156,0,"VIP Health Care Portfolio Buys Thermo Fisher Scientific Inc, Royalty Pharma PLC, Charles River ...",headlinesIter239.csv
2021-12-17,CVS,100.36000061035156,70.40365248257963,1.7177936604464956,100.31999969482422,0,"ASYMmetric ETFs Trust Buys Coterra Energy Inc, Baxter International Inc, Newmont Corp, Sells ...",headlinesIter240.csv
2021-12-20,CVS,100.31999969482422,70.20005721238387,1.8808547606937025,100.79000091552734,1,"Hedge Funds Are Selling Monolithic Power Systems, Inc. (MPWR)",headlinesIter241.csv
2021-12-21,CVS,100.79000091552734,71.2520040837111,2.021475701037887,100.9000015258789,1,"Hedge Funds Are Selling Monolithic Power Systems, Inc. (MPWR)",headlinesIter242.csv
2021-12-22,CVS,100.9000015258789,71.50552849029461,2.137807645302701,101.30999755859376,1,Top Stocks for January 2022,headlinesIter243.csv
2021-12-23,CVS,101.30999755859376,72.47969822965354,2.234486155821154,102.4000015258789,1,Top Stocks for January 2022,headlinesIter244.csv
2021-12-27,CVS,102.4000015258789,74.93330114867972,2.326075758289467,102.7699966430664,1,Has Bio-Rad Laboratories (BIO) Outpaced Other Medical Stocks This Year?,headlinesIter245.csv
2021-12-28,CVS,102.7699966430664,75.7244756901512,2.410275912305276,103.6999969482422,1,Here's Why You Should Invest in Bio-Rad (BIO) Stock Now,headlinesIter246.csv
2021-12-29,CVS,103.6999969482422,77.63525647122314,2.494774697334468,103.68000030517578,0,Here's Why You Should Invest in Bio-Rad (BIO) Stock Now,headlinesIter247.csv
2021-12-30,CVS,103.68000030517578,77.49401277222344,2.56902596162112,103.16000366210938,0,Here's Why You Should Invest in Bio-Rad (BIO) Stock Now,headlinesIter248.csv
2022-01-03,CVS,104.16000366210938,76.13340083701627,2.6606351655398632,104.29000091552734,1,Here's Why You Should Invest in Bio-Rad (BIO) Stock Now,headlinesIter249.csv
2022-01-04,CVS,104.29000091552734,76.43441468722125,2.691288493444953,105.80999755859376,1,Here's Why You Should Invest in Bio-Rad (BIO) Stock Now,headlinesIter250.csv
2022-01-05,CVS,105.80999755859376,79.66405035591649,2.7314495077071053,102.58999633789062,0,Bio-Rad to Participate in Fireside Chat During the 40th Annual J.P. Morgan Healthcare Conference on January 11,headlinesIter251.csv
2022-01-06,CVS,102.58999633789062,60.688985451698585,2.7178656840605,104.19000244140624,1,Bio-Rad to Participate in Fireside Chat During the 40th Annual J.P. Morgan Healthcare Conference on January 11,headlinesIter252.csv
2022-01-07,CVS,104.19000244140624,65.13309332640979,2.690640320948396,105.05999755859376,1,Bio-Rad to Participate in Fireside Chat During the 40th Annual J.P. Morgan Healthcare Conference on January 11,headlinesIter253.csv
2022-01-10,CVS,105.05999755859376,67.2979314327542,2.6640396541278726,106.04000091552734,1,Bio-Rad to Participate in Fireside Chat During the 40th Annual J.P. Morgan Healthcare Conference on January 11,headlinesIter254.csv
2022-01-11,CVS,106.04000091552734,69.58850971660071,2.648788481692452,105.77999877929688,0,Bio-Rad to Participate in Fireside Chat During the 40th Annual J.P. Morgan Healthcare Conference on January 11,headlinesIter255.csv
2022-01-12,CVS,105.77999877929688,68.22318503483775,2.631265137146746,105.33999633789062,0,"Shilanski &amp; Associates, Inc. Buys Olin Corp, Coterra Energy Inc, Fortinet Inc, Sells Staar ...",headlinesIter256.csv
2022-01-13,CVS,105.33999633789062,65.86794396326485,2.600219074349716,106.22000122070312,1,"Bio Rad's (BIO) Product Launches Aid, Forex Woes Persist",headlinesIter257.csv
2022-01-14,CVS,106.22000122070312,68.23022818839316,2.570438258345976,104.51000213623048,0,Hedge Funds Are Souring On Xylem Inc (XYL) Anymore,headlinesIter258.csv
2022-01-18,CVS,104.51000213623048,59.59845221312957,2.5098710486934315,103.4499969482422,0,Hedge Funds Are Souring On Xylem Inc (XYL) Anymore,headlinesIter259.csv
2022-01-19,CVS,103.4499969482422,54.957105773993774,2.4105502896482376,102.38999938964844,0,Hedge Funds Are Souring On Xylem Inc (XYL) Anymore,headlinesIter260.csv
2022-01-20,CVS,102.38999938964844,50.70466313323346,2.2697403412588977,101.55999755859376,0,Hedge Funds Are Souring On Xylem Inc (XYL) Anymore,headlinesIter261.csv
2022-01-21,CVS,101.55999755859376,47.59888613084646,2.0918918711252235,103.51000213623048,1,Hedge Funds Are Souring On Xylem Inc (XYL) Anymore,headlinesIter262.csv
2022-01-24,CVS,103.51000213623048,54.63011606038636,1.926494823226795,103.0999984741211,0,Hedge Funds Are Souring On Xylem Inc (XYL) Anymore,headlinesIter263.csv
2022-01-25,CVS,103.0999984741211,53.01924381437478,1.7666402317576868,104.86000061035156,1,"Bio-Rad to Report Fourth-Quarter and Full-Year 2021 Financial Results, Thursday, February 10, 2022",headlinesIter264.csv
2022-01-26,CVS,104.86000061035156,58.65511326901509,1.6426926621545812,106.79000091552734,1,"Bio-Rad to Report Fourth-Quarter and Full-Year 2021 Financial Results, Thursday, February 10, 2022",headlinesIter265.csv
2022-01-27,CVS,106.79000091552734,63.78552253625118,1.5747964534360286,109.2699966430664,1,"Bio-Rad to Report Fourth-Quarter and Full-Year 2021 Financial Results, Thursday, February 10, 2022",headlinesIter266.csv
2022-01-28,CVS,109.2699966430664,69.0927615426719,1.5815689870151766,106.51000213623048,0,"Bio-Rad to Report Fourth-Quarter and Full-Year 2021 Financial Results, Thursday, February 10, 2022",headlinesIter267.csv
2022-01-31,CVS,106.51000213623048,58.77023883334768,1.5871485982574132,106.2699966430664,0,"Bio-Rad to Report Fourth-Quarter and Full-Year 2021 Financial Results, Thursday, February 10, 2022",headlinesIter268.csv
2022-02-01,CVS,106.2699966430664,57.959325822783626,1.584241436276567,108.9000015258789,1,Top Stocks for February 2022,headlinesIter269.csv
2022-02-02,CVS,108.9000015258789,63.84627072117207,1.6145167126606703,108.72000122070312,0,Bio-Rad to Host Investor Day on February 25,headlinesIter270.csv
2022-02-03,CVS,108.72000122070312,63.19404514507795,1.657451408633688,108.48999786376952,0,Earnings Preview: Bio-Rad Laboratories (BIO) Q4 Earnings Expected to Decline,headlinesIter271.csv
2022-02-04,CVS,108.48999786376952,62.318010092588,1.6986228395865433,109.41000366210938,1,Bio-Rad (BIO) to Report Q4 Earnings: What's in the Cards?,headlinesIter272.csv
2022-02-07,CVS,109.41000366210938,64.44140602497069,1.747337465881465,110.83000183105467,1,Was The Smart Money Right About Dover Corporation (DOV)?,headlinesIter273.csv
2022-02-08,CVS,110.83000183105467,67.48676978014454,1.816899025580424,104.79000091552734,0,"Freedom Day Solutions, LLC Buys Dick's Sporting Goods Inc, Polaris Inc, Roblox Corp, Sells ...",headlinesIter274.csv
2022-02-09,CVS,104.79000091552734,48.47110796851805,1.795374739988811,105.31999969482422,1,"Medical Device Stocks' Q4 Earnings on Feb 10: BIO, DXCM &amp; LH",headlinesIter275.csv
2022-02-10,CVS,105.31999969482422,49.80756085397032,1.72225174859387,104.23999786376952,0,Bio-Rad Reports Fourth-Quarter and Full-Year 2021 Financial Results,headlinesIter276.csv
2022-02-11,CVS,104.23999786376952,47.125356851182126,1.5994647575184533,103.0,0,"Bio-Rad (BIO) Q4 Earnings Surpass Estimates, Margins Down",headlinesIter277.csv
2022-02-14,CVS,103.0,44.183396859513735,1.4285570851409253,102.97000122070312,0,10 Best Healthcare Stocks To Buy In 2022,headlinesIter278.csv
2022-02-15,CVS,102.97000122070312,44.11165002528688,1.232712981005868,103.94000244140624,1,"Ecolab (ECL) Q4 Earnings &amp; Revenues Beat Mark, Margins Down",headlinesIter279.csv
2022-02-16,CVS,103.94000244140624,47.10274470685524,1.0441718768154291,102.3000030517578,0,Wall Street Analysts Think Bio-Rad (BIO) Could Surge 42%: Read This Before Placing a Bet,headlinesIter280.csv
2022-02-17,CVS,102.3000030517578,42.9203219166986,0.8415466763897651,102.12999725341795,0,Baxter (BAX) Q4 Earnings and Revenues Surpass Estimates,headlinesIter281.csv
2022-02-18,CVS,102.12999725341795,42.49904696255244,0.6360853868024722,101.91999816894533,0,AMN Healthcare (AMN) Q4 Earnings and Revenues Top Estimates,headlinesIter282.csv
2022-02-22,CVS,101.91999816894533,41.95129195043788,0.4348169317746069,102.23999786376952,1,"Medtronic's (MDT) Q3 Earnings Beat, Revenues Lag Estimates",headlinesIter283.csv
2022-02-23,CVS,102.23999786376952,43.153630437860855,0.250841661707376,100.7699966430664,0,"Bio-Rad Laboratories, Inc. -- Moody's assigns Baa2 rating to Bio-Rad; outlook stable",headlinesIter284.csv
2022-02-24,CVS,100.7699966430664,39.14276153111316,0.0633249827947676,104.3000030517578,1,"Insulet (PODD) Q4 Earnings Surpass Estimates, Margins Up",headlinesIter285.csv
2022-02-25,CVS,104.3000030517578,50.93585731705284,-0.0604065882875093,103.6500015258789,0,Bio-Rad Presents Growth Strategy and Acceleration of Financial Targets at Investor Day,headlinesIter286.csv
2022-02-28,CVS,103.6500015258789,49.050964323389046,-0.1479053919729377,102.0500030517578,0,Here's Why You Should Invest In Henry Schein (HSIC) Now,headlinesIter287.csv
2022-03-01,CVS,102.0500030517578,44.6690886839591,-0.2332973020013301,104.43000030517578,1,Here's Why You Should Retain CVS Health (CVS) Stock for Now,headlinesIter288.csv
2022-03-02,CVS,104.43000030517578,51.595939911644784,-0.274389068981828,104.54000091552734,1,Henry Schein (HSIC) Expands Data Analytics to Private Practices,headlinesIter289.csv
2022-03-03,CVS,104.54000091552734,51.89568727626571,-0.2831798825260495,105.19000244140624,1,Medtronic (MDT) Gains Market Share Despite COVID Headwinds,headlinesIter290.csv
2022-03-04,CVS,105.19000244140624,53.71948120383047,-0.2602484363091977,104.55999755859376,0,Thermo Fisher (TMO) Extends Collaboration With Symphogen,headlinesIter291.csv
2022-03-07,CVS,104.55999755859376,51.67453199448383,-0.2280943976640176,102.36000061035156,0,Here's Why You Should Invest in Bio-Rad (BIO) Stock Now,headlinesIter292.csv
2022-03-08,CVS,102.36000061035156,45.20334257418692,-0.2264251777335472,103.5999984741211,1,"Bio-Rad's (BIO) Product Launches Aid Growth, Global Arm Strong",headlinesIter293.csv
2022-03-09,CVS,103.5999984741211,49.07438047422439,-0.2236512443690639,104.08000183105467,1,Here's Why You Should Retain Charles River (CRL) Stock For Now,headlinesIter294.csv
2022-03-10,CVS,104.08000183105467,50.53122280549553,-0.212162392554724,103.47000122070312,0,Medtronic (MDT) Inks Deal to Offer Touch Surgery Enterprise,headlinesIter295.csv
2022-03-11,CVS,103.47000122070312,48.62739395044902,-0.2050621057499028,104.48999786376952,1,Here's Why You Should Hold Onto Neogen (NEOG) Stock for Now,headlinesIter296.csv
2022-03-14,CVS,104.48999786376952,51.89135085298127,-0.1843438665049973,106.9800033569336,1,Here's Why You Should Hold Onto Neogen (NEOG) Stock for Now,headlinesIter297.csv
2022-03-15,CVS,106.9800033569336,58.77691534869247,-0.1160295025032962,107.11000061035156,1,Here's Why You Should Hold Onto Neogen (NEOG) Stock for Now,headlinesIter298.csv
2022-03-16,CVS,107.11000061035156,59.1059901593924,-0.0191254764787837,108.55999755859376,1,Here's Why You Should Hold Onto Neogen (NEOG) Stock for Now,headlinesIter299.csv
2022-03-17,CVS,108.55999755859376,62.6841902256277,0.1137955719317862,107.3000030517578,0,Reasons to Hold on to Myriad Genetics (MYGN) Stock For Now,headlinesIter300.csv
2022-03-18,CVS,107.3000030517578,57.93992360822114,0.2419616116197128,107.38999938964844,1,Reasons to Hold on to Myriad Genetics (MYGN) Stock For Now,headlinesIter301.csv
2022-03-21,CVS,107.38999938964844,58.183368676298805,0.3613129879277308,107.2300033569336,0,"Walgreens (WBA), Village MD Plan to Expand Into New Hampshire",headlinesIter302.csv
2022-03-22,CVS,107.2300033569336,57.54567418447816,0.4655067589901864,106.1999969482422,0,Myriad Genetics (MYGN) Makes Progress in Precision Oncology,headlinesIter303.csv
2022-03-23,CVS,106.1999969482422,53.48184381821447,0.5372438923391476,108.0500030517578,1,Henry Schein (HSIC) Stock Moves Up 16.9%: What's Driving It?,headlinesIter304.csv
2022-03-24,CVS,108.0500030517578,59.07242342722071,0.6131685342784969,108.55999755859376,1,Here's Why You Should Hold on to Thermo Fisher (TMO) Stock Now,headlinesIter305.csv
2022-03-25,CVS,108.55999755859376,60.48236874169128,0.6944768596624613,108.04000091552734,0,"Neogen's (NEOG) Q3 Earnings Miss Estimates, Margins Down",headlinesIter306.csv
2022-03-28,CVS,108.04000091552734,58.27787108088758,0.7650181607781883,104.68000030517578,0,Medtronic (MDT) Completes 1st Patient Implant of Implantable TNM,headlinesIter307.csv
2022-03-29,CVS,104.68000030517578,46.48721700260035,0.7697625296257298,103.5500030517578,0,Here's Why You Should Hold on to Align Technology (ALGN) Now,headlinesIter308.csv
2022-03-30,CVS,103.5500030517578,43.31341819170487,0.7132350576509451,101.20999908447266,0,Omnicell (OMCL) Progresses With Intelligent Infrastructure Tools,headlinesIter309.csv
2022-03-31,CVS,101.20999908447266,37.59015347563571,0.5823078427716216,101.08999633789062,0,Here's Why You Should Hold on to Exact Sciences (EXAS) Stock,headlinesIter310.csv
2022-04-01,CVS,101.08999633789062,37.31782256001128,0.4083699602561282,100.0,0,Bio-Rad (BIO) Thrives on Global Sales and Testing Uptake,headlinesIter311.csv
2022-04-04,CVS,100.0,34.84824699371754,0.1982709230338946,99.45999908447266,0,Here's Why You Should Retain CVS Health (CVS) Stock For Now,headlinesIter312.csv
2022-04-05,CVS,99.45999908447266,33.65982146319145,-0.032546785458917,102.05999755859376,1,Abbott (ABT) Aveir VR Leadless Pacemaker Receives FDA Nod,headlinesIter313.csv
2022-04-06,CVS,102.05999755859376,43.62803808092768,-0.222695072184818,103.61000061035156,1,Bruker (BRKR) to Support Biopharma Industries With New Buyout,headlinesIter314.csv
2022-04-07,CVS,103.61000061035156,48.58769931555398,-0.3521477053150832,106.61000061035156,1,Walgreens (WBA) Expands Medical Care Offerings in California,headlinesIter315.csv
2022-04-08,CVS,106.61000061035156,56.55485803380085,-0.3881054939869756,104.4499969482422,0,Here's Why You Should Invest In Henry Schein (HSIC) Now,headlinesIter316.csv
2022-04-11,CVS,104.4499969482422,50.48826586118582,-0.3971545847107695,104.63999938964844,1,Here's Why You Should Hold on to Walgreens Boots (WBA) For Now,headlinesIter317.csv
2022-04-12,CVS,104.63999938964844,50.98632569774813,-0.3849268829629326,104.9800033569336,1,Alcon (ALC) Stock Rallies 4.7% Since Posting Q4 Earnings Beat,headlinesIter318.csv
2022-04-13,CVS,104.9800033569336,51.91842368006228,-0.3537024052755892,103.68000030517578,0,Bruker (BRKR) Unveils New Imaging Tools for Cancer Research,headlinesIter319.csv
2022-04-14,CVS,103.68000030517578,48.14818134643392,-0.3321425852759361,103.41999816894533,0,Bruker (BRKR) Unveils New Imaging Tools for Cancer Research,headlinesIter320.csv
2022-04-18,CVS,103.41999816894533,47.406692451761096,-0.3211617489627661,103.86000061035156,1,"Bio-Rad to Report First-Quarter Financial Results, Thursday, April 28, 2022",headlinesIter322.csv
2022-04-19,CVS,103.86000061035156,48.8425022430214,-0.309635273698439,106.63999938964844,1,Here's Why You Should Retain Bio-Rad (BIO) Stock For Now,headlinesIter323.csv
2022-04-20,CVS,106.63999938964844,56.856605613621255,-0.2533120610910564,105.18000030517578,0,Here's Why You Should Retain Bio-Rad (BIO) Stock For Now,headlinesIter324.csv
2022-04-21,CVS,105.18000030517578,52.22906186960778,-0.1945797605083992,101.68000030517578,0,Top Healthcare Stocks for May 2022,headlinesIter325.csv
2022-04-22,CVS,101.68000030517578,43.1601929232385,-0.1928133037085123,101.7699966430664,1,Top Healthcare Stocks for May 2022,headlinesIter326.csv
2022-04-25,CVS,101.7699966430664,43.43218221285104,-0.2249692352339058,101.43000030517578,0,Bio-Rad (BIO) to Report Q1 Earnings: What's in the Cards?,headlinesIter327.csv
2022-04-26,CVS,101.43000030517578,42.60276868085084,-0.2816130881139848,100.8499984741211,0,Bio-Rad (BIO) to Report Q1 Earnings: What's in the Cards?,headlinesIter328.csv
2022-04-27,CVS,100.8499984741211,41.15878649169888,-0.3592478685964914,100.8499984741211,0,"Medical Products Stocks' Earnings on Apr 28: TMO, BIO &amp; More",headlinesIter329.csv
2022-04-28,CVS,100.8499984741211,41.15878649169888,-0.4451508137991687,96.12999725341795,0,Bio-Rad Laboratories (BIO) Surpasses Q1 Earnings and Revenue Estimates,headlinesIter330.csv
2022-04-29,CVS,96.12999725341795,31.18340243956707,-0.6060231841631167,96.5,1,"Bio-Rad (BIO) Q1 Earnings Surpass Estimates, Margins Up",headlinesIter331.csv
2022-05-02,CVS,96.5,32.5631880598431,-0.7981673151897237,95.9800033569336,0,"Bio-Rad (BIO) Q1 Earnings Surpass Estimates, Margins Up",headlinesIter332.csv
2022-05-03,CVS,95.9800033569336,31.60413507160757,-1.0063165250878865,100.56999969482422,1,"Bio-Rad (BIO) Q1 Earnings Surpass Estimates, Margins Up",headlinesIter333.csv
2022-05-04,CVS,100.56999969482422,46.564496177658405,-1.138061573098176,97.7300033569336,0,"Bio-Rad (BIO) Q1 Earnings Surpass Estimates, Margins Up",headlinesIter334.csv
2022-05-05,CVS,97.7300033569336,40.64113537635512,-1.2577282898691169,100.69000244140624,1,"Estimating The Intrinsic Value Of Bio-Rad Laboratories, Inc. (NYSE:BIO)",headlinesIter335.csv
2022-05-06,CVS,100.69000244140624,48.05755280342402,-1.3134597417791325,98.86000061035156,0,"Estimating The Intrinsic Value Of Bio-Rad Laboratories, Inc. (NYSE:BIO)",headlinesIter336.csv
2022-05-09,CVS,98.86000061035156,44.36682856729528,-1.3523992434781362,98.16000366210938,0,"Estimating The Intrinsic Value Of Bio-Rad Laboratories, Inc. (NYSE:BIO)",headlinesIter337.csv
2022-05-10,CVS,98.16000366210938,43.00628886870088,-1.3868582541164278,97.98999786376952,0,"Estimating The Intrinsic Value Of Bio-Rad Laboratories, Inc. (NYSE:BIO)",headlinesIter338.csv
2022-05-11,CVS,97.98999786376952,42.66409858192506,-1.41625399420859,98.25,1,"Estimating The Intrinsic Value Of Bio-Rad Laboratories, Inc. (NYSE:BIO)",headlinesIter339.csv
2022-05-12,CVS,98.25,43.40576020337012,-1.4335590895825148,97.4800033569336,0,"Estimating The Intrinsic Value Of Bio-Rad Laboratories, Inc. (NYSE:BIO)",headlinesIter340.csv
2022-05-13,CVS,97.4800033569336,41.6860072643044,-1.451396316969583,98.5500030517578,1,7 Profitable Places to Hide Your Money During a Bear Market,headlinesIter341.csv
2022-05-16,CVS,98.5500030517578,44.95004497312623,-1.448252771463141,99.37999725341795,1,7 Profitable Places to Hide Your Money During a Bear Market,headlinesIter342.csv
2022-05-17,CVS,99.37999725341795,47.40910450526192,-1.4155807400714526,94.0199966430664,0,7 Profitable Places to Hide Your Money During a Bear Market,headlinesIter343.csv
2022-05-18,CVS,94.0199966430664,36.17190838365829,-1.448402832066558,93.13999938964844,0,7 Profitable Places to Hide Your Money During a Bear Market,headlinesIter344.csv
2022-05-19,CVS,93.13999938964844,34.71698742049221,-1.5312934226538932,94.93000030517578,1,7 Profitable Places to Hide Your Money During a Bear Market,headlinesIter345.csv
2022-05-20,CVS,94.93000030517578,40.00329019185608,-1.6091721698178854,95.56999969482422,1,7 Profitable Places to Hide Your Money During a Bear Market,headlinesIter346.csv
2022-05-23,CVS,95.56999969482422,41.817369171507565,-1.6659486126547025,96.4499969482422,1,7 Profitable Places to Hide Your Money During a Bear Market,headlinesIter347.csv
2022-05-24,CVS,96.4499969482422,44.31073873426425,-1.6886853489119178,97.1500015258789,1,7 Profitable Places to Hide Your Money During a Bear Market,headlinesIter348.csv
2022-05-25,CVS,97.1500015258789,46.28275843273151,-1.6738777395607571,97.8000030517578,1,Wall Street Analysts Believe Bio-Rad (BIO) Could Rally 53%: Here's is How to Trade,headlinesIter349.csv
2022-05-26,CVS,97.8000030517578,48.11988427999474,-1.622128800413721,98.0500030517578,1,Cooper Companies (COO) to Post Q2 Earnings: What's in Store?,headlinesIter350.csv
2022-05-27,CVS,98.0500030517578,48.8445330732701,-1.5422527526766046,96.75,0,Cooper Companies (COO) to Post Q2 Earnings: What's in Store?,headlinesIter351.csv
2022-05-31,CVS,96.75,45.30109850947447,-1.4661600960399097,96.54000091552734,0,The 4.8% return this week takes Bio-Rad Laboratories' (NYSE:BIO) shareholders five-year gains to 140%,headlinesIter352.csv
2022-06-01,CVS,96.54000091552734,44.736514835708775,-1.3964364357576946,97.2300033569336,1,Ebay Tops BofA List of Companies with High Free Cash Flow,headlinesIter353.csv
2022-06-02,CVS,97.2300033569336,47.07069144137927,-1.3201684214204863,94.9000015258789,0,Ebay Tops BofA List of Companies with High Free Cash Flow,headlinesIter354.csv
2022-06-03,CVS,94.9000015258789,40.80337219888997,-1.2779615155974535,95.72000122070312,1,Why Is NuVasive (NUVA) Up 6.3% Since Last Earnings Report?,headlinesIter355.csv
2022-06-06,CVS,95.72000122070312,43.64710995898897,-1.2433206594518278,95.91999816894533,1,"Bio-Rad (BIO) Immunohematology Arm Recovers, New Launches Aid",headlinesIter356.csv
2022-06-07,CVS,95.91999816894533,44.34930463773205,-1.2092133738030404,93.87999725341795,0,"Bio-Rad (BIO) Immunohematology Arm Recovers, New Launches Aid",headlinesIter357.csv
2022-06-08,CVS,93.87999725341795,39.00973756811631,-1.2070194613541203,92.73999786376952,0,"Bio-Rad (BIO) Immunohematology Arm Recovers, New Launches Aid",headlinesIter358.csv
2022-06-09,CVS,92.73999786376952,36.37418636169616,-1.2403802244208084,93.16999816894533,1,"Bio-Rad (BIO) Immunohematology Arm Recovers, New Launches Aid",headlinesIter359.csv
2022-06-10,CVS,93.16999816894533,38.07369137917927,-1.28458966180227,90.88999938964844,0,"Bio-Rad (BIO) Immunohematology Arm Recovers, New Launches Aid",headlinesIter360.csv
2022-06-13,CVS,90.88999938964844,33.035038367088454,-1.3667295155257633,90.63999938964844,0,"Bio-Rad (BIO) Immunohematology Arm Recovers, New Launches Aid",headlinesIter361.csv
2022-06-14,CVS,90.63999938964844,32.52673842399772,-1.4692110634780686,91.4499969482422,1,"Bio-Rad (BIO) Immunohematology Arm Recovers, New Launches Aid",headlinesIter362.csv
2022-06-15,CVS,91.4499969482422,35.96464034912028,-1.5627984720261268,89.8499984741211,0,"Bio-Rad (BIO) Immunohematology Arm Recovers, New Launches Aid",headlinesIter363.csv
2022-06-16,CVS,89.8499984741211,32.447690962904474,-1.6678703070449523,88.66000366210938,0,What's in Store for Patterson Companies' (PDCO) Q4 Earnings?,headlinesIter364.csv
2022-06-17,CVS,88.66000366210938,30.0908260571012,-1.7898165772798809,91.08000183105467,1,Here's Why You Should Invest in Bio-Rad (BIO) Stock Now,headlinesIter365.csv
2022-06-21,CVS,91.08000183105467,39.685443899414935,-1.8732577801851835,91.29000091552734,1,Is Bio-Rad Laboratories (NYSE:BIO) Using Too Much Debt?,headlinesIter366.csv
2022-06-22,CVS,91.29000091552734,40.44922338205591,-1.9205706809731928,92.37000274658205,1,Is Bio-Rad Laboratories (NYSE:BIO) Using Too Much Debt?,headlinesIter367.csv
2022-06-23,CVS,92.37000274658205,44.352113297799065,-1.9211506739578144,94.5199966430664,1,Is Bio-Rad Laboratories (NYSE:BIO) Using Too Much Debt?,headlinesIter368.csv
2022-06-24,CVS,94.5199966430664,51.20774088206152,-1.8537283935887583,94.54000091552734,1,Is Bio-Rad Laboratories (NYSE:BIO) Using Too Much Debt?,headlinesIter369.csv
2022-06-27,CVS,94.54000091552734,51.26789756862248,-1.74267381458816,93.1999969482422,0,Investors are Watching These 10 Biotech Stocks,headlinesIter370.csv
2022-06-28,CVS,93.1999969482422,47.08051897584192,-1.627500095188129,93.3499984741211,1,Investors are Watching These 10 Biotech Stocks,headlinesIter371.csv
2022-06-29,CVS,93.3499984741211,47.59649713012033,-1.5096795864092147,92.66000366210938,0,Investors are Watching These 10 Biotech Stocks,headlinesIter372.csv
2022-06-30,CVS,92.66000366210938,45.40349114125562,-1.403944066166814,93.94000244140624,1,Investors are Watching These 10 Biotech Stocks,headlinesIter373.csv
2022-07-01,CVS,93.94000244140624,50.00538373832099,-1.2877045078432094,92.52999877929688,0,Investors are Watching These 10 Biotech Stocks,headlinesIter374.csv
2022-07-05,CVS,92.52999877929688,45.45975402107885,-1.190535537544753,93.19000244140624,1,Investors are Watching These 10 Biotech Stocks,headlinesIter375.csv
2022-07-06,CVS,93.19000244140624,47.84947272660804,-1.097169956081557,93.7300033569336,1,Investors are Watching These 10 Biotech Stocks,headlinesIter376.csv
2022-07-07,CVS,93.7300033569336,49.7879919614854,-0.9999665716293628,94.18000030517578,1,Investors are Watching These 10 Biotech Stocks,headlinesIter377.csv
2022-07-08,CVS,94.18000030517578,51.40893438920969,-0.8959947240685676,94.70999908447266,1,Investors are Watching These 10 Biotech Stocks,headlinesIter378.csv
2022-07-11,CVS,94.70999908447266,53.3202757856848,-0.7827329368152071,94.9800033569336,1,Investors are Watching These 10 Biotech Stocks,headlinesIter379.csv
2022-07-12,CVS,94.9800033569336,54.30636898449017,-0.6634939982167276,93.4499969482422,0,Investors are Watching These 10 Biotech Stocks,headlinesIter380.csv
2022-07-13,CVS,93.4499969482422,48.10500474353331,-0.5696575207703416,92.83000183105467,0,"Is Now The Time To Look At Buying Bio-Rad Laboratories, Inc. (NYSE:BIO)?",headlinesIter381.csv
2022-07-14,CVS,92.83000183105467,45.82158233070292,-0.505255172321412,95.37000274658205,1,"Is Now The Time To Look At Buying Bio-Rad Laboratories, Inc. (NYSE:BIO)?",headlinesIter382.csv
2022-07-15,CVS,95.37000274658205,55.20312046057576,-0.4210018333485236,94.29000091552734,0,"Is Now The Time To Look At Buying Bio-Rad Laboratories, Inc. (NYSE:BIO)?",headlinesIter383.csv
2022-07-18,CVS,94.29000091552734,51.14758532212424,-0.3449942274498743,96.79000091552734,1,"Bio-Rad to Report Second Quarter 2022 Financial Results on Thursday, July 28, 2022",headlinesIter384.csv
2022-07-19,CVS,96.79000091552734,58.70954577203942,-0.2374669800780285,95.1500015258789,0,"Bio-Rad to Report Second Quarter 2022 Financial Results on Thursday, July 28, 2022",headlinesIter385.csv
2022-07-20,CVS,95.1500015258789,52.92225781530585,-0.1414445852005056,93.19000244140624,0,"Bio-Rad to Report Second Quarter 2022 Financial Results on Thursday, July 28, 2022",headlinesIter386.csv
2022-07-21,CVS,93.19000244140624,46.9638901192708,-0.0886151214323368,94.05999755859376,1,"Bio-Rad to Report Second Quarter 2022 Financial Results on Thursday, July 28, 2022",headlinesIter387.csv
2022-07-22,CVS,94.05999755859376,49.67246132663308,-0.0515453221200004,94.48999786376952,1,Bio-Rad (BIO) to Report Q2 Earnings: What's in the Cards?,headlinesIter388.csv
2022-07-25,CVS,94.48999786376952,51.0043345518701,-0.0193187493630755,95.30999755859376,1,Bio-Rad (BIO) to Report Q2 Earnings: What's in the Cards?,headlinesIter389.csv
2022-07-26,CVS,95.30999755859376,53.52990985670857,0.0213094601733027,95.87000274658205,1,Bio-Rad (BIO) to Report Q2 Earnings: What's in the Cards?,headlinesIter390.csv
2022-07-27,CVS,95.87000274658205,55.22728988582121,0.0739598421330584,95.52999877929688,0,Medical Device Stocks to Watch for Earnings on Jul 28,headlinesIter391.csv
2022-07-28,CVS,95.52999877929688,53.939082613741306,0.1257923346756639,95.68000030517578,1,Bio-Rad Laboratories (BIO) Surpasses Q2 Earnings and Revenue Estimates,headlinesIter392.csv
2022-07-29,CVS,95.68000030517578,54.44394670514562,0.1765015256303074,96.0199966430664,1,"Bio-Rad (BIO) Q2 Earnings Surpass Estimates, Gross Margin Up",headlinesIter393.csv
2022-08-01,CVS,96.0199966430664,55.63103878037411,0.2288705536469593,95.37000274658205,0,"Bio-Rad (BIO) Q2 Earnings Surpass Estimates, Gross Margin Up",headlinesIter394.csv
2022-08-02,CVS,95.37000274658205,52.79847674991851,0.2686427491134845,101.37999725341795,1,"Bio-Rad (BIO) Q2 Earnings Surpass Estimates, Gross Margin Up",headlinesIter395.csv
2022-08-03,CVS,101.37999725341795,68.67857662785507,0.3937082308517423,101.87000274658205,1,Bio-Rad Acquires Curiosity Diagnostics,headlinesIter396.csv
2022-08-04,CVS,101.87000274658205,69.57726078817292,0.5725981635667373,102.26000213623048,1,12 Best Healthcare Stocks To Buy Now,headlinesIter397.csv
2022-08-05,CVS,102.26000213623048,70.30749158910193,0.7807636589714884,102.0,0,12 Best Healthcare Stocks To Buy Now,headlinesIter398.csv
2022-08-08,CVS,102.0,69.11641224964823,0.9904384301204892,103.69000244140624,1,12 Best Healthcare Stocks To Buy Now,headlinesIter399.csv
2022-08-09,CVS,103.69000244140624,72.39051626799228,1.214773280478526,104.0500030517578,1,12 Best Healthcare Stocks To Buy Now,headlinesIter400.csv
2022-08-10,CVS,104.0500030517578,73.04603922645595,1.439511666372136,104.25,1,12 Best Healthcare Stocks To Buy Now,headlinesIter401.csv
2022-08-11,CVS,104.25,73.42355176081348,1.652631719201479,106.38999938964844,1,12 Best Healthcare Stocks To Buy Now,headlinesIter402.csv
2022-08-12,CVS,106.38999938964844,77.11674145786162,1.877673279040712,106.2699966430664,0,12 Best Healthcare Stocks To Buy Now,headlinesIter403.csv
2022-08-15,CVS,106.2699966430664,76.47496148241932,2.092195787133623,106.43000030517578,1,Levin Easterly Partners’ Latest Portfolio: Top 10 Stock Picks,headlinesIter404.csv
2022-08-16,CVS,106.43000030517578,76.75276150901128,2.2866637605969204,104.91999816894533,0,Levin Easterly Partners’ Latest Portfolio: Top 10 Stock Picks,headlinesIter405.csv
2022-08-17,CVS,104.91999816894533,68.52835498567703,2.4290646363348407,103.63999938964844,0,Levin Easterly Partners’ Latest Portfolio: Top 10 Stock Picks,headlinesIter406.csv
2022-08-18,CVS,103.63999938964844,62.42221942204519,2.5054080121118187,104.0500030517578,1,4 Stocks to Watch Amid Recovering Medical Products Industry,headlinesIter407.csv
2022-08-19,CVS,104.0500030517578,63.542798044135566,2.537176818066627,102.33999633789062,0,4 Stocks to Watch Amid Recovering Medical Products Industry,headlinesIter408.csv
2022-08-22,CVS,102.33999633789062,56.03724428609917,2.506276876321849,101.12999725341795,0,Here's Why You Should Invest in Bio-Rad (BIO) Stock Now,headlinesIter409.csv
2022-08-23,CVS,101.12999725341795,51.40986812734158,2.412700062953397,101.27999877929688,1,Here's Why You Should Invest in Bio-Rad (BIO) Stock Now,headlinesIter410.csv
2022-08-24,CVS,101.27999877929688,51.93970211209896,2.281638207144291,102.1500015258789,1,Here's Why You Should Invest in Bio-Rad (BIO) Stock Now,headlinesIter411.csv
2022-08-25,CVS,102.1500015258789,55.00429259087476,2.142632002688712,100.05999755859376,0,Cooper Companies (COO) to Post Q3 Earnings: What's in Store?,headlinesIter412.csv
2022-08-26,CVS,100.05999755859376,47.21532120550891,1.967705084959091,100.33000183105467,1,Cooper Companies (COO) to Post Q3 Earnings: What's in Store?,headlinesIter413.csv
2022-08-29,CVS,100.33000183105467,48.23514867335826,1.7792566806874432,98.8000030517578,0,What's in Store for Patterson Companies (PDCO) in Q1 Earnings?,headlinesIter414.csv
2022-08-30,CVS,98.8000030517578,43.1478931938265,1.563746524537564,98.1500015258789,0,What's in Store for Patterson Companies (PDCO) in Q1 Earnings?,headlinesIter415.csv
2022-08-31,CVS,98.1500015258789,41.16170124043176,1.328637495724991,99.93000030517578,1,What's in Store for Patterson Companies (PDCO) in Q1 Earnings?,headlinesIter416.csv
2022-09-01,CVS,99.93000030517578,48.19449021866908,1.118939684325071,99.44000244140624,0,Cooper Companies (COO) Q3 Earnings &amp; Revenues Top Estimates,headlinesIter417.csv
2022-09-02,CVS,99.44000244140624,46.54518363379636,0.9257939178709425,98.7300033569336,0,Cooper Companies (COO) Q3 Earnings &amp; Revenues Top Estimates,headlinesIter418.csv
2022-09-06,CVS,98.7300033569336,44.18561202279289,0.7397099804295962,100.68000030517578,1,Cooper Companies (COO) Q3 Earnings &amp; Revenues Top Estimates,headlinesIter419.csv
2022-09-07,CVS,100.68000030517578,51.46324250160112,0.597232201841656,102.26000213623048,1,Cooper Companies (COO) Q3 Earnings &amp; Revenues Top Estimates,headlinesIter420.csv
2022-09-08,CVS,102.26000213623048,56.42145259851872,0.5134016328440281,102.1500015258789,0,Cooper Companies (COO) Q3 Earnings &amp; Revenues Top Estimates,headlinesIter421.csv
2022-09-09,CVS,102.1500015258789,55.99260103687153,0.4677993939181435,103.04000091552734,1,Cooper Companies (COO) Q3 Earnings &amp; Revenues Top Estimates,headlinesIter422.csv
2022-09-12,CVS,103.04000091552734,58.72609187840173,0.4616816874108237,100.4499969482422,0,Cooper Companies (COO) Q3 Earnings &amp; Revenues Top Estimates,headlinesIter423.csv
2022-09-13,CVS,100.4499969482422,49.15696362135535,0.43825855459323,101.0500030517578,1,Cooper Companies (COO) Q3 Earnings &amp; Revenues Top Estimates,headlinesIter424.csv
2022-09-14,CVS,101.0500030517578,51.14309138098444,0.4137904622075358,102.30999755859376,1,Cooper Companies (COO) Q3 Earnings &amp; Revenues Top Estimates,headlinesIter425.csv
2022-09-15,CVS,102.30999755859376,55.1089156432824,0.4091094315410138,102.05999755859376,0,Cooper Companies (COO) Q3 Earnings &amp; Revenues Top Estimates,headlinesIter426.csv
2022-09-16,CVS,102.05999755859376,54.16937122601494,0.4121548880461392,102.11000061035156,1,Cooper Companies (COO) Q3 Earnings &amp; Revenues Top Estimates,headlinesIter427.csv
2022-09-19,CVS,102.11000061035156,54.33705865994328,0.4197418942876626,101.33999633789062,0,Cooper Companies (COO) Q3 Earnings &amp; Revenues Top Estimates,headlinesIter428.csv
2022-09-20,CVS,101.33999633789062,51.22864452126312,0.4165360873837513,99.7699966430664,0,Cooper Companies (COO) Q3 Earnings &amp; Revenues Top Estimates,headlinesIter429.csv
